沃森生物(300142)
 
 
  日线
顶尖财经网欢迎您!
  K线
 
 最新动态
  投资评级

  盈利预测
据沃森生物四季报分析:

  盈利能力维持稳定,企业经营效益下降

  成长能力有所加强,营利增速步入上升通道

  偿债能力维持稳定,偿还流动负债具有较好保障

  运营能力维持稳定,存货的周转速度需要加快

  现金流能力明显恶化,公司现金回收质量略差

  财务数据
2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
每股收益(元)0.070.110.100.030.000.090.160.11
每股净资产(元)4.635.396.055.945.905.906.005.92
每股资本公积金(元)1.312.132.842.842.842.842.843.01
每股未分配利润(元)2.081.791.991.911.901.891.971.90
每股经营性现金流(元)-0.010.310.050.07-0.100.650.350.06
净资产收益率(%)1.411.911.720.450.031.512.711.81
营业总收入(元)4.44亿24.18亿17.19亿11.54亿4.62亿28.21亿21.41亿14.33亿
营业总收入同比增长(%)-3.98-14.29-19.73-19.47-22.93-31.41-32.19-33.88
归属净利润(元)1.11亿1.78亿1.63亿4316.06万264.62万1.42亿2.56亿1.71亿
归属净利润同比增长(%)4082.4125.03-36.24-74.69-81.27-66.10-53.67-62.53
扣非净利润(元)1.14亿9545.09万7054.00万2844.27万-1149.02万1.08亿2.24亿1.46亿
扣非净利润同比增长(%)1089.20-11.94-68.50-80.52-113.67-81.10-59.84-65.39
毛利率(%)68.4774.5671.6970.2871.4879.6979.4280.00
净利率(%)25.785.186.02-0.61-4.266.1816.3717.97
资产负债率(%)29.7920.9917.4223.1120.0221.8421.8222.86
存货周转率(次)0.250.930.750.500.180.640.450.28
  主营收入+营业利润
 
  净利润+每股收益
  股东权益+未分配利润
 
  总资产+负债
  投资要点
  • 总资产(亿元)
  • 负债(亿元)
    截至2026年第一季度最新总资产1112828.47万元,负债331481.42万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入443,848,309.812,418,234,933.461,718,807,933.371,154,212,387
营业总成本406,874,077.192,107,110,191.821,488,300,078.09975,738,044.24
其他经营收益
营业利润131,054,857.36187,949,310.11140,353,629.7513,928,276.59
利润总额128,938,125.59166,112,393.23136,278,616.6712,042,491.96
净利润114,413,869.69125,157,091.43103,512,939.99-7,094,241.99
每股收益
其他综合收益-213,017,400106,250,00039,950,000
综合收益总额114,413,869.69338,174,491.43209,762,939.9932,855,758.01
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计4,329,045,639.344,546,332,984.655,912,282,709.356,727,743,135.54
非流动资产:
非流动资产合计6,799,239,065.427,524,256,256.617,339,582,207.347,274,758,697.41
资产总计11,128,284,704.7612,070,589,241.2613,251,864,916.6914,002,501,832.95
流动负债:
流动负债合计2,001,918,172.991,937,123,384.71,678,427,087.042,388,098,966.11
非流动负债:
非流动负债合计1,312,896,044.42597,073,860.22630,232,463.27848,104,682.44
负债合计3,314,814,217.412,534,197,244.922,308,659,550.313,236,203,648.55
所有者权益(或股东权益):
归属于母公司股东权益合计7,408,481,999.528,620,990,550.959,683,242,545.419,496,660,286.66
股东权益合计7,813,470,487.359,536,391,996.3410,943,205,366.3810,766,298,184.4
负债和股东权益合计11,128,284,704.7612,070,589,241.2613,251,864,916.6914,002,501,832.95
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计468,908,289.542,788,916,431.971,850,051,940.041,193,669,127.43
经营活动现金流出小计489,147,342.582,297,990,265.811,770,359,850.281,077,012,043.08
经营活动产生的现金流量净额-20,239,053.04490,926,166.1679,692,089.76116,657,084.35
投资活动产生的现金流量:
投资活动现金流入小计6,661,283.13192,895,570.81161,922,690.01191,389
投资活动现金流出小计144,889,103.18509,544,939.65357,253,150.1141,478,824.71
投资活动产生的现金流量净额-138,227,820.05-316,649,368.84-195,330,460.09-141,287,435.71
筹资活动产生的现金流量:
筹资活动现金流入小计977,260,053.13305,800,605.752,440,0002,440,000
筹资活动现金流出小计1,200,265,9272,889,984,280.21,969,865,412.911,204,374,595.64
筹资活动产生的现金流量净额-223,005,873.87-2,584,183,674.45-1,967,425,412.91-1,201,934,595.64
汇率变动对现金及现金等价物的影响-1,147,114.85-951,793.34908,358.771,233,445.54
现金及现金等价物净增加额-382,619,861.81-2,410,858,670.47-2,082,155,424.47-1,225,331,501.46
期末现金及现金等价物余额965,624,283.731,348,244,145.541,676,947,391.542,533,771,314.55
补充资料:
现金及现金等价物的净增加额--2,410,858,670.47--1,225,331,501.46
  十大流通股东
  主力控盘
  公司简介



以上信息为合作方、加盟公司及会员收集,本站不拥有版权,版权归原作者所有,所载文章、数据仅供参考,据此操作,风险自负。

中 华 顶 尖 财 经 -- 中 华 顶 尖 网 络 信 息 服 务 中 心